December 2025 Final Primary and Secondary Endpoint Results Lexaria reported results from its fourth human diabetes weight loss study designated GLP-1-H24-4 study on December 23 rd , 2025
In a statement to Rolling Stone , Novo Nordisk said that patient safety is a top priority, and the updated labeling was in coordination with the FDA to monitor the safety profile of the drug
In this article, we will look at how GLP-1 weight loss is influencing the demand for body contouring, lifting, and skin-focused procedures, and how we help patients plan their next steps safely and strategically
It keeps your metabolism humming, your bones resilient, your energy steady, and your body feeling strong and ready for whatever you throw at it
Energy consumption mode optimization: GLP-1RA increases basal metabolic rate (BMR) by activating brown adipose tissue thermogenesis and promoting mitochondrial biosynthesis in muscle tissue
For most modern GH axis research designs where isolated GH effects are the goal, Ipamorelin is the preferred compound
